Table II.

Antihypertensive Agents Used in Our Study, Divided by Class, With Adequate Dosages

Angiotensin‐converting enzyme inhibitors

Captopril 150 mg/d

Enalapril 20 mg/d

Fosinopril 20 mg/d

Lisinopril 20 mg/d

Aldosterone antagonists

Spironolactone 25 mg/d

α‐Blockers

Doxazosin 4 mg/d

Prazosin 10 mg/d

Terazosin 5 mg/d

Angiotensin receptor blockers

Candesartan 16 mg/d

Irbesartan 150 mg/d

Valsartan 160 mg/d

β‐Blockers

Atenolol 50 mg/d

Carvedilol 25 mg/d

Labetalol 600 mg/d

Metoprolol 100 mg/d (either formulation)

Propranolol 80 mg/d

Calcium channel blockers (dihydropyridines)

Amlodipine 5 mg/d

Felodipine 5 mg/d

Nifedipine 60 mg/d

Calcium channel blockers (nondihydropyridines)

Diltiazem 180 mg/d

Verapamil 180 mg/d

Centrally acting vasodilators (each is a unique drug class)

Clonidine

Patch 0.2 mg

Tablets 0.6 mg/d

Hydralazine 100 mg/d

Minoxidil 20 mg/d

Diuretics (loop)

Bumetanide 1 mg/d

Furosemide 40 mg/d

Diuretics (thiazide)

Chlorthalidone 25 mg/d

Hydrochlorothiazide 25 mg/d

Metolazone 0.5 mg/d